Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.

Source:http://linkedlifedata.com/resource/pubmed/id/19366274

Download in:

View as

General Info

PMID
19366274